NCT06477107
A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion
Completed
NAAges 18+InterventionalSupportive careMayo ClinicInvestigator-initiated
~7 participants
Updated 2026-08-05 on ClinicalTrials.gov
What's tested:Soterix® 4x1HD-TDCSSoterix® 1x1 tDCSCognitive training program
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Changes in cerebral blood flow
Measured over Phase 1 Day 0 and Phase 2 Day 0, 14, 44, and 58
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Zafer Keser · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Vasculopathy leading to imaging evidence of hypoperfusion
Cognitive impairment
Exclusion
Pregnancy
Contraindication to MRI or tDCS including metallic implanted objects.
Medical instability or inability to cooperate during the study as assessed by the treating physician to participate in the study.
What this trial measures
- Changes in cerebral blood flowPhase 1 Day 0 and Phase 2 Day 0, 14, 44, and 58
Cerebral blood flow imaging assessed by MRI to measure blood flow through the blood vessels reported in millimeters of mercury (mmHg)